Clinical Trial Update: Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study of aminopterin in methotrexate-naïve rheumatoid arthritis has completed. The trial was sponsored by Syntrix Biosystems, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Aminopterin (Aminopterin)

Snippet

Sponsor: Syntrix Biosystems, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED